190 related articles for article (PubMed ID: 24503272)
1. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
Liu Y; Lin H; Zhu Q; Wu C; Zhao Z; Zheng H
Vaccine; 2014 Mar; 32(15):1768-73. PubMed ID: 24503272
[TBL] [Abstract][Full Text] [Related]
2. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013.
Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H
Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510
[TBL] [Abstract][Full Text] [Related]
3. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
4. Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.
Wang Y; Dong D; Cheng G; Zuo S; Liu D; Du X
Vaccine; 2014 Oct; 32(44):5875-9. PubMed ID: 25173477
[TBL] [Abstract][Full Text] [Related]
5. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.
Rabe IB; Miller ER; Fischer M; Hills SL
Vaccine; 2015 Jan; 33(5):708-12. PubMed ID: 25498208
[TBL] [Abstract][Full Text] [Related]
6. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
Nakayama T; Onoda K
Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
[TBL] [Abstract][Full Text] [Related]
7. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
[TBL] [Abstract][Full Text] [Related]
8. Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
Ginsburg AS; Meghani A; Halstead SB; Yaich M
Hum Vaccin Immunother; 2017 Oct; 13(10):2222-2231. PubMed ID: 28841362
[TBL] [Abstract][Full Text] [Related]
9. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
[TBL] [Abstract][Full Text] [Related]
10. Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009.
Lindsey NP; Staples JE; Jones JF; Sejvar JJ; Griggs A; Iskander J; Miller ER; Fischer M
Vaccine; 2010 Dec; 29(1):58-64. PubMed ID: 20970488
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for preventing Japanese encephalitis.
Schiøler KL; Samuel M; Wai KL
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD004263. PubMed ID: 17636750
[TBL] [Abstract][Full Text] [Related]
12. Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
Chotpitayasunondh T; Pruekprasert P; Puthanakit T; Pancharoen C; Tangsathapornpong A; Oberdorfer P; Kosalaraksa P; Prommalikit O; Tangkittithaworn S; Kerdpanich P; Techasaensiri C; Korejwo J; Chuenkitmongkol S; Houillon G
Vaccine; 2017 Jan; 35(2):299-304. PubMed ID: 27903416
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Sabchareon A; Pancharoen C; Bouckenooghe A; Gailhardou S; Boaz M; Feroldi E
Pediatr Infect Dis J; 2010 Dec; 29(12):1111-7. PubMed ID: 20856164
[TBL] [Abstract][Full Text] [Related]
14. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
15. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
16. Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product.
Zaman K; Naser AM; Power M; Yaich M; Zhang L; Ginsburg AS; Luby SP; Rahman M; Hills S; Bhardwaj M; Flores J
Vaccine; 2014 Oct; 32(46):6061-6. PubMed ID: 25239483
[TBL] [Abstract][Full Text] [Related]
17. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.
Khan SA; Kakati S; Dutta P; Chowdhury P; Borah J; Topno R; Jadhav SM; Mohapatra PK; Mahanta J; Gupte MD
Indian J Med Res; 2016 Dec; 144(6):886-892. PubMed ID: 28474625
[TBL] [Abstract][Full Text] [Related]
19. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
Sricharoenchai S; Lapphra K; Chuenkitmongkol S; Phongsamart W; Bouckenooghe A; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Feb; 36(2):e45-e47. PubMed ID: 27846060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
